| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and causes motility disorders
1 Veterinary Pharmacology, Univ of Tokyo, Tokyo, Japan
2 NIAH, Paratubercurosis and IBD Research Team, Tsukuba, Japan
3 IMS, Univ of Tokyo, Tokyo, Japan
4 Molecular Physiology ad Medical Bioregulation, Yamaguchi Univ, Yamaguchi, Japan
5 Molecular Physiology ad Medical Bioregulation, Yamaguchi Univ, United States
* To whom correspondence should be addressed. E-mail: aozaki{at}mail.ecc.u-tokyo.ac.jp.
Motility disorders are frequently observed in intestinal inflammation. We previously reported that in vitro treatment of intestinal smooth muscle tissue with IL-1
decreases the expression of CPI-17, an endogenous inhibitory protein of smooth muscle serine/threonine protein phosphatase, thereby inhibiting contraction. The present study was performed to examine the pathophysiological importance of CPI-17 expression in the motility disorders using an in vivo model of intestinal inflammation and to define the regulatory mechanism of CPI-17 expression by pro-inflammatory cytokines. After induction of acute ileitis with TNBS, CPI-17 expression declined in a time-dependent manner. Parallel with this decrease in CPI-17, cholinergic agonist-induced contraction of strips of smooth muscle and sensitivity of permeabilized smooth muscle fibers to Ca2+ were reduced. Among the various pro-inflammatory cytokines tested, TNF-
and IL-1 were observed to directly inhibit CPI-17 expression and contraction, in cultured rat intestinal tissue. Moreover, both TNF- and IL-1 inhibited CPI-17 expression and contraction of smooth muscle tissue isolated from wild-type and IL-1,double KO mice. However, IL-1-treatment failed to inhibit CPI-17 expression and contraction in TNF- KO mice. These findings suggest that CPI-17 was down-regulated during intestinal inflammation, and that TNF- plays a central role in this process. Down-regulation of CPI-17 may play a role in motility impairments in inflammation.
This article has been cited by other articles:
|
|
 |
|
  E. Ihara, P. L. Beck, M. Chappellaz, J. Wong, S. A. Medlicott, and J. A. MacDonald Mitogen-Activated Protein Kinase Pathways Contribute to Hypercontractility and Increased Ca2+ Sensitization in Murine Experimental Colitis Mol. Pharmacol., May 1, 2009; 75(5): 1031 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohama, M. Okada, T. Murata, D. L. Brautigan, M. Hori, and H. Ozaki Sphingosine-1-phosphate enhances IL-1{beta}-induced COX-2 expression in mouse intestinal subepithelial myofibroblasts Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G766 - G775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hu, S. Mahavadi, F. Li, and K. S. Murthy Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1 Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
